Jane Street Group, LLC Axsome Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 130,097 shares of AXSM stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,097

Previous 168,434 22.76%

Holding current value

$11.8 Million

Previous $13.6 Million 13.79%

% of portfolio

0.0%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $3.03 Million - $3.67 Million	-38,337 Reduced 22.76%	130,097 $11.7 Million
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $2.01 Million - $2.47 Million	-30,645 Reduced 15.39%	168,434 $13.6 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $7.37 Million - $10.4 Million	106,248 Added 114.45%	199,079 $15.9 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $1.88 Million - $2.74 Million	-32,750 Reduced 26.08%	92,831 $7.39 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $10.4 Million - $12.4 Million	-150,321 Reduced 54.48%	125,581 $8.78 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $14.8 Million - $23 Million	254,158 Added 1168.86%	275,902 $19.8 Million
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $9 Million - $11.6 Million	-154,155 Reduced 87.64%	21,744 $1.34 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $278,421 - $555,728	-6,971 Reduced 3.81%	175,899 $13.6 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $5.08 Million - $9.85 Million	140,975 Added 336.5%	182,870 $8.16 Million
Q2 2022 Aug 16, 2022	BUY	$21.74 - $46.75 $29,044 - $62,458	1,336 Added 3.29%	41,895 $1.6 Million
Q1 2022 May 17, 2022	SELL	$23.7 - $41.39 $8.49 Million - $14.8 Million	-358,235 Reduced 89.83%	40,559 $1.68 Million
Q4 2021 Feb 15, 2022	BUY	$30.7 - $43.36 $3.24 Million - $4.57 Million	105,462 Added 35.95%	398,794 $15.1 Million
Q3 2021 Nov 16, 2021	BUY	$19.91 - $68.26 $3.8 Million - $13 Million	190,621 Added 185.59%	293,332 $9.67 Million
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $533,589 - $774,616	10,539 Added 11.43%	102,711 $6.93 Million
Q1 2021 May 18, 2021	BUY	$55.91 - $81.44 $1.11 Million - $1.62 Million	19,918 Added 27.57%	92,172 $5.22 Million
Q4 2020 Feb 17, 2021	SELL	$66.31 - $86.52 $7.1 Million - $9.26 Million	-107,001 Reduced 59.69%	72,254 $5.89 Million
Q3 2020 Nov 17, 2020	BUY	$68.34 - $85.84 $8.15 Million - $10.2 Million	119,216 Added 198.56%	179,255 $12.8 Million
Q2 2020 Aug 17, 2020	SELL	$49.87 - $98.69 $2.5 Million - $4.95 Million	-50,121 Reduced 45.5%	60,039 $4.94 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $2.37 Million - $5.82 Million	-57,496 Reduced 34.29%	110,160 $6.48 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $2.59 Million - $16.5 Million	155,206 Added 1246.63%	167,656 $17.3 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $7,934 - $11,430	392 Added 3.25%	12,450 $252,000
Q2 2019 Aug 15, 2019	SELL	$13.46 - $25.75 $95,458 - $182,619	-7,092 Reduced 37.03%	12,058 $310,000
Q1 2019 May 16, 2019	BUY	$2.63 - $16.34 $50,364 - $312,911	19,150 New	19,150 $273,000

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Axsome Therapeutics, Inc. Transaction History